Literature DB >> 19400292

Development of mu/delta opioid ligands: enkephalin analogues containing 4-anilidopiperidine moiety.

YeonSun Lee1, Ravil Petrov, Vinod Kulkarni, Byoung J Min, Shou-Wu Ma, Peg Davis, Janice Oyarzo, Todd Vanderah, Josephine Lai, Frank Porreca, Ruben Vardanyan, Victor J Hruby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19400292      PMCID： PMC5632930          DOI： 10.1007/978-0-387-73657-0_225

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

1.  Virtual computational chemistry laboratory--design and description.

Authors:  Igor V Tetko; Johann Gasteiger; Roberto Todeschini; Andrea Mauri; David Livingstone; Peter Ertl; Vladimir A Palyulin; Eugene V Radchenko; Nikolay S Zefirov; Alexander S Makarenko; Vsevolod Yu Tanchuk; Volodymyr V Prokopenko
Journal:  J Comput Aided Mol Des       Date:  2005-06       Impact factor: 3.686

2.  Design and synthesis of novel hydrazide-linked bifunctional peptides as delta/mu opioid receptor agonists and CCK-1/CCK-2 receptor antagonists.

Authors:  Yeon Sun Lee; Richard S Agnes; Hamid Badghisi; Peg Davis; Shou-wu Ma; Josephine Lai; Frank Porreca; Victor J Hruby
Journal:  J Med Chem       Date:  2006-03-09       Impact factor: 7.446

3.  Understanding the structural requirements of 4-anilidopiperidine analogues for biological activities at mu and delta opioid receptors.

Authors:  Yeon Sun Lee; Joel Nyberg; Sharif Moye; Richard S Agnes; Peg Davis; Shou-wu Ma; Josephine Lai; Frank Porreca; Ruben Vardanyan; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2007-02-08       Impact factor: 2.823

4.  Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.

Authors:  P J Horan; K D Wild; A Misicka; A Lipkowski; R C Haaseth; V J Hruby; S J Weber; T P Davis; H I Yamamura; F Porreca
Journal:  J Pharmacol Exp Ther       Date:  1993-05       Impact factor: 4.030

5.  Profound spinal tolerance after repeated exposure to a highly selective mu-opioid peptide agonist: role of delta-opioid receptors.

Authors:  Guo-Min Zhao; Dunli Wu; Yi Soong; Megumi Shimoyama; Irena Berezowska; Peter W Schiller; Hazel H Szeto
Journal:  J Pharmacol Exp Ther       Date:  2002-07       Impact factor: 4.030
  5 in total
  2 in total

Review 1.  Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications.

Authors:  Ruben S Vardanyan; Victor J Hruby
Journal:  Future Med Chem       Date:  2014-03       Impact factor: 3.808

2.  Synthesis and Investigation of Mixed μ-Opioid and δ-Opioid Agonists as Possible Bivalent Ligands for Treatment of Pain.

Authors:  Ruben S Vardanyan; James P Cain; Saghar Mowlazadeh Haghighi; Vlad K Kumirov; Mary I McIntosh; Alexander J Sandweiss; Frank Porreca; Victor J Hruby
Journal:  J Heterocycl Chem       Date:  2016-06-01       Impact factor: 2.193
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.